Physician profile
Devangi V Patel
NPI 1366811440
$3,062.59
in general payments reported to CMS, 2019-2025
11 companies · $321 in 2025
The $321 reported for 2025 was more than what 87% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $190 · 2021: $336 · 2022: $782 · 2023: $1,161 · 2024: $273 · 2025: $321.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,755.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,755.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,157.91 | 2020-2025 | Watchman Flx, Enroute Transcarotid Neuroprotection System, Eluvia |
| Cumberland Pharmaceuticals, INC. | $573.56 | 2020-2024 | Vibativ |
| Silk Road Medical, INC. | $527.68 | 2021-2023 | Enroute Transcarotid Stent, Enroute Transcarotid Neuroprotection System |
| Abbott Laboratories | $322.92 | 2023-2025 | Amplatzer Amulet |
| Fisher & Paykel Healthcare INC | $162.11 | 2023 | Fisher & Paykel Healthcare |
| Biosense Webster, INC. | $147.50 | 2021-2022 | |
| W. L. Gore & Associates, INC. | $72.16 | 2023 | Gore Viabahn Vbx Balloon Expandable Endo |
| Aroa Biosurgery Incorporated | $56.67 | 2022-2024 | |
| Merck Sharp & Dohme LLC | $17.36 | 2023 | Bridion |
| Medtronic, INC. | $12.75 | 2021 | |
| Ambu INC. | $11.97 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Devangi Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.